Measuring the impact of PCV7 in the European Union: why it is a priority.
Lopalco
P L
PL
European Centre for Disease Prevention and Control, Stockholm, Sweden. Pierluigi.Lopalco@ecdc.europa.eu
D000328:Adult; D002648:Child; D005062:European Union; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D022401:Meningococcal Vaccines / Q000627:therapeutic use*; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use*; D011159:Population Surveillance / Q000379:methods; D015397:Program Evaluation
D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines